| 0 |
NONINFECTIVE CHORIORETINITIS |
1 |
0.0333 |
| 1 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
13 |
0.0145 |
| 2 |
PELVIC ORGAN INJURY |
1 |
0.0135 |
| 3 |
INTRAPARTUM HAEMORRHAGE |
1 |
0.0125 |
| 4 |
POST PROCEDURAL ERYTHEMA |
1 |
0.0112 |
| 5 |
LABOUR PAIN |
1 |
0.0110 |
| 6 |
SPINAL LIGAMENT OSSIFICATION |
1 |
0.0109 |
| 7 |
EYE NAEVUS |
1 |
0.0088 |
| 8 |
UTERINE HAEMATOMA |
1 |
0.0079 |
| 9 |
COAGULATION FACTOR VIII LEVEL INCREASED |
1 |
0.0068 |
| 10 |
VITREOUS DEGENERATION |
1 |
0.0061 |
| 11 |
COAGULATION FACTOR VIII LEVEL DECREASED |
1 |
0.0061 |
| 12 |
FACTOR VIII DEFICIENCY |
1 |
0.0056 |
| 13 |
EPIDURAL INJECTION |
1 |
0.0051 |
| 14 |
THORACIC HAEMORRHAGE |
1 |
0.0050 |
| 15 |
PRODUCT CONTAMINATION WITH BODY FLUID |
1 |
0.0049 |
| 16 |
SPLENIC ARTERY ANEURYSM |
1 |
0.0048 |
| 17 |
PRODUCT WITH QUALITY ISSUE ADMINISTERED |
2 |
0.0045 |
| 18 |
BREAST HAEMATOMA |
1 |
0.0044 |
| 19 |
POST PROCEDURAL PULMONARY EMBOLISM |
1 |
0.0043 |
| 20 |
METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS |
1 |
0.0039 |
| 21 |
CHEST WALL HAEMATOMA |
1 |
0.0039 |
| 22 |
PRODUCT IMPURITY |
1 |
0.0036 |
| 23 |
FALLOPIAN TUBE DISORDER |
1 |
0.0034 |
| 24 |
ADNEXAL TORSION |
1 |
0.0032 |
| 25 |
SPONTANEOUS HAEMORRHAGE |
3 |
0.0029 |
| 26 |
POSTERIOR CAPSULE OPACIFICATION |
1 |
0.0029 |
| 27 |
PTERYGIUM |
1 |
0.0029 |
| 28 |
ENDOMETRIAL ABLATION |
1 |
0.0028 |
| 29 |
SOFT TISSUE HAEMORRHAGE |
1 |
0.0027 |
| 30 |
GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC |
1 |
0.0027 |
| 31 |
DELUSIONAL PERCEPTION |
1 |
0.0024 |
| 32 |
HAEMORRHOID OPERATION |
1 |
0.0022 |
| 33 |
HAEMARTHROSIS |
18 |
0.0020 |
| 34 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 35 |
GASTROINTESTINAL POLYP HAEMORRHAGE |
1 |
0.0017 |
| 36 |
BONE OPERATION |
1 |
0.0015 |
| 37 |
DELIVERY |
1 |
0.0015 |
| 38 |
POSTPARTUM HAEMORRHAGE |
2 |
0.0015 |
| 39 |
PRODUCT DEPOSIT |
2 |
0.0013 |
| 40 |
MUSCLE HAEMORRHAGE |
5 |
0.0012 |
| 41 |
HEAVY MENSTRUAL BLEEDING |
11 |
0.0012 |
| 42 |
PERITONSILLAR ABSCESS |
1 |
0.0012 |
| 43 |
PRODUCT SOLUBILITY ABNORMAL |
6 |
0.0012 |
| 44 |
PRODUCT CONTAMINATION PHYSICAL |
3 |
0.0012 |
| 45 |
OPTICAL COHERENCE TOMOGRAPHY ABNORMAL |
1 |
0.0012 |
| 46 |
MUSCLE SWELLING |
1 |
0.0011 |
| 47 |
CATHETER SITE SWELLING |
1 |
0.0011 |
| 48 |
RETINAL EXUDATES |
1 |
0.0011 |
| 49 |
FACTOR VIII INHIBITION |
1 |
0.0010 |
| 50 |
METABOLIC SURGERY |
1 |
0.0009 |
| 51 |
MOUTH HAEMORRHAGE |
6 |
0.0008 |
| 52 |
PHARYNGEAL HAEMORRHAGE |
1 |
0.0008 |
| 53 |
SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
1 |
0.0008 |
| 54 |
OVARIAN CYST RUPTURED |
1 |
0.0008 |
| 55 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 56 |
PROCEDURAL HAEMORRHAGE |
3 |
0.0008 |
| 57 |
INFUSION SITE RASH |
1 |
0.0007 |
| 58 |
LIQUID PRODUCT PHYSICAL ISSUE |
5 |
0.0007 |
| 59 |
VASCULAR DEVICE INFECTION |
3 |
0.0007 |
| 60 |
POOR VENOUS ACCESS |
6 |
0.0006 |
| 61 |
AORTIC VALVE STENOSIS |
1 |
0.0006 |
| 62 |
UTERINE SPASM |
1 |
0.0005 |
| 63 |
BODY TEMPERATURE ABNORMAL |
1 |
0.0005 |
| 64 |
OCULAR HYPERTENSION |
1 |
0.0005 |
| 65 |
GINGIVAL BLEEDING |
7 |
0.0005 |
| 66 |
EAR HAEMORRHAGE |
1 |
0.0005 |
| 67 |
PRODUCT CONTAINER ISSUE |
4 |
0.0005 |
| 68 |
VITREOUS DETACHMENT |
1 |
0.0005 |
| 69 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 70 |
PRODUCT PREPARATION ISSUE |
3 |
0.0005 |
| 71 |
WALKING AID USER |
3 |
0.0005 |
| 72 |
EPISTAXIS |
34 |
0.0005 |
| 73 |
COLONOSCOPY |
1 |
0.0005 |
| 74 |
PREGNANCY |
9 |
0.0004 |
| 75 |
INTERNAL HAEMORRHAGE |
5 |
0.0004 |
| 76 |
NECK SURGERY |
1 |
0.0004 |
| 77 |
POST PROCEDURAL HAEMORRHAGE |
5 |
0.0004 |
| 78 |
VOLVULUS |
1 |
0.0004 |
| 79 |
PULSE ABNORMAL |
1 |
0.0004 |
| 80 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 81 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 82 |
ENDODONTIC PROCEDURE |
1 |
0.0004 |
| 83 |
INSURANCE ISSUE |
6 |
0.0004 |
| 84 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 85 |
MENSTRUAL DISORDER |
3 |
0.0004 |
| 86 |
THERAPEUTIC RESPONSE DELAYED |
1 |
0.0004 |
| 87 |
DEVICE DEFECTIVE |
6 |
0.0003 |
| 88 |
HAEMOTHORAX |
1 |
0.0003 |
| 89 |
HAEMORRHAGE |
35 |
0.0003 |
| 90 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 91 |
METABOLIC ENCEPHALOPATHY |
1 |
0.0003 |
| 92 |
EMBOLISM VENOUS |
1 |
0.0003 |
| 93 |
DEVICE FAILURE |
5 |
0.0003 |
| 94 |
LOOSE TOOTH |
1 |
0.0003 |
| 95 |
POLYP |
2 |
0.0003 |
| 96 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
1 |
0.0003 |
| 97 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 98 |
NO ADVERSE EVENT |
53 |
0.0003 |
| 99 |
AORTIC STENOSIS |
1 |
0.0003 |
| 100 |
APPENDICECTOMY |
1 |
0.0003 |
| 101 |
SKIN LACERATION |
3 |
0.0003 |
| 102 |
TENDON INJURY |
1 |
0.0003 |
| 103 |
CLAVICLE FRACTURE |
1 |
0.0003 |
| 104 |
CONCUSSION |
2 |
0.0003 |
| 105 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 106 |
BLEPHARITIS |
1 |
0.0002 |
| 107 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 108 |
UTERINE HAEMORRHAGE |
1 |
0.0002 |
| 109 |
ABDOMINAL ABSCESS |
1 |
0.0002 |
| 110 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 111 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 112 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 113 |
GASTROINTESTINAL HAEMORRHAGE |
18 |
0.0002 |
| 114 |
SKIN ABRASION |
1 |
0.0002 |
| 115 |
SUBCUTANEOUS ABSCESS |
1 |
0.0002 |
| 116 |
INABILITY TO AFFORD MEDICATION |
2 |
0.0002 |
| 117 |
ENDOCARDITIS |
1 |
0.0002 |
| 118 |
DEVICE RELATED INFECTION |
3 |
0.0002 |
| 119 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 120 |
HAEMATOMA |
5 |
0.0002 |
| 121 |
TENDERNESS |
2 |
0.0002 |
| 122 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 123 |
HEAD INJURY |
6 |
0.0002 |
| 124 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 125 |
LIMB INJURY |
5 |
0.0002 |
| 126 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 127 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
1 |
0.0002 |
| 128 |
GASTRIC HAEMORRHAGE |
2 |
0.0002 |
| 129 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 130 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 131 |
PLEURISY |
1 |
0.0002 |
| 132 |
CARDIAC PACEMAKER INSERTION |
1 |
0.0002 |
| 133 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
1 |
0.0002 |
| 134 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 135 |
POST PROCEDURAL COMPLICATION |
3 |
0.0002 |
| 136 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 137 |
MENINGITIS |
1 |
0.0001 |
| 138 |
PRODUCT PHYSICAL ISSUE |
3 |
0.0001 |
| 139 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 140 |
PROCEDURAL PAIN |
4 |
0.0001 |
| 141 |
JOINT INJURY |
3 |
0.0001 |
| 142 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 143 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
3 |
0.0001 |
| 144 |
VAGINAL HAEMORRHAGE |
6 |
0.0001 |
| 145 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 146 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 147 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 148 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 149 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 150 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 151 |
DEVICE MALFUNCTION |
9 |
0.0001 |
| 152 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 153 |
BLOOD DISORDER |
1 |
0.0001 |
| 154 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 155 |
MUSCLE INJURY |
1 |
0.0001 |
| 156 |
HEMIPLEGIA |
1 |
0.0001 |
| 157 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 158 |
DEVICE USE ISSUE |
2 |
0.0001 |
| 159 |
OPTIC NEURITIS |
1 |
0.0001 |
| 160 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 161 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 162 |
BLOOD URINE PRESENT |
2 |
0.0001 |
| 163 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 164 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 165 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 166 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 167 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 168 |
BRAIN INJURY |
1 |
0.0001 |
| 169 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 170 |
VAGINAL DISCHARGE |
1 |
0.0001 |
| 171 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 172 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 173 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 174 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 175 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 176 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 177 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 178 |
HAEMATOCHEZIA |
5 |
0.0001 |
| 179 |
PRODUCT USE ISSUE |
17 |
0.0001 |
| 180 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 181 |
TOOTH DISORDER |
2 |
0.0001 |
| 182 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 183 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 184 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 185 |
BACTERAEMIA |
1 |
0.0001 |
| 186 |
ACCIDENT |
1 |
0.0001 |
| 187 |
CONTUSION |
8 |
0.0001 |
| 188 |
HEPATITIS C |
1 |
0.0001 |
| 189 |
CARDIOMEGALY |
1 |
0.0001 |
| 190 |
SPINAL OPERATION |
1 |
0.0001 |
| 191 |
EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 192 |
GENITAL HAEMORRHAGE |
1 |
0.0001 |
| 193 |
DEEP VEIN THROMBOSIS |
5 |
0.0001 |
| 194 |
JOINT STIFFNESS |
2 |
0.0001 |
| 195 |
TOOTH INFECTION |
1 |
0.0001 |
| 196 |
DYSMENORRHOEA |
1 |
0.0001 |
| 197 |
MENSTRUATION IRREGULAR |
2 |
0.0001 |
| 198 |
ARTHROPATHY |
4 |
0.0001 |
| 199 |
HUNGER |
1 |
0.0001 |
| 200 |
HAEMOPTYSIS |
2 |
0.0001 |
| 201 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 202 |
RECTAL HAEMORRHAGE |
3 |
0.0001 |
| 203 |
ANKLE FRACTURE |
1 |
0.0001 |
| 204 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 205 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 206 |
SEIZURE |
7 |
0.0001 |
| 207 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 208 |
INFLAMMATION |
3 |
0.0001 |
| 209 |
SYRINGE ISSUE |
1 |
0.0001 |
| 210 |
PRODUCT STORAGE ERROR |
5 |
0.0001 |
| 211 |
METASTASES TO LIVER |
1 |
0.0001 |
| 212 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
4 |
0.0001 |
| 213 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 214 |
DEVICE ISSUE |
5 |
0.0001 |
| 215 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 216 |
PANIC ATTACK |
2 |
0.0001 |
| 217 |
PRODUCT DOSE OMISSION ISSUE |
16 |
0.0001 |
| 218 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 219 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 220 |
FOOT FRACTURE |
1 |
0.0001 |
| 221 |
GLAUCOMA |
1 |
0.0001 |
| 222 |
HAEMORRHOIDS |
1 |
0.0001 |
| 223 |
ORAL HERPES |
1 |
0.0001 |
| 224 |
FALL |
17 |
0.0001 |
| 225 |
MENORRHAGIA |
1 |
0.0001 |
| 226 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 227 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
9 |
0.0000 |
| 228 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 229 |
EXTRA DOSE ADMINISTERED |
2 |
0.0000 |
| 230 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 231 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 232 |
ILLNESS |
5 |
0.0000 |
| 233 |
RETCHING |
1 |
0.0000 |
| 234 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 235 |
SKIN CANCER |
1 |
0.0000 |
| 236 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 237 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 238 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 239 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 240 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 241 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 242 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 243 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 244 |
HEPATIC CANCER |
1 |
0.0000 |
| 245 |
NEURALGIA |
1 |
0.0000 |
| 246 |
UNDERDOSE |
3 |
0.0000 |
| 247 |
LIVER INJURY |
1 |
0.0000 |
| 248 |
HAEMATEMESIS |
1 |
0.0000 |
| 249 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 250 |
THROMBOSIS |
3 |
0.0000 |
| 251 |
PALLOR |
1 |
0.0000 |
| 252 |
DEVICE DELIVERY SYSTEM ISSUE |
1 |
0.0000 |
| 253 |
RESPIRATORY ARREST |
1 |
0.0000 |
| 254 |
FEELING COLD |
1 |
0.0000 |
| 255 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 256 |
ANGINA PECTORIS |
1 |
0.0000 |
| 257 |
HYPERSOMNIA |
1 |
0.0000 |
| 258 |
GENERAL PHYSICAL HEALTH DETERIORATION |
4 |
0.0000 |
| 259 |
INFECTION |
5 |
0.0000 |
| 260 |
NEEDLE ISSUE |
1 |
0.0000 |
| 261 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 262 |
COVID-19 |
6 |
0.0000 |
| 263 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 264 |
HEPATIC FAILURE |
1 |
0.0000 |
| 265 |
JOINT SWELLING |
4 |
0.0000 |
| 266 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 267 |
VERTIGO |
2 |
0.0000 |
| 268 |
EPILEPSY |
1 |
0.0000 |
| 269 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 270 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 271 |
VISUAL IMPAIRMENT |
4 |
0.0000 |
| 272 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 273 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 274 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 275 |
HIP FRACTURE |
1 |
0.0000 |
| 276 |
SWELLING FACE |
2 |
0.0000 |
| 277 |
DEVICE DIFFICULT TO USE |
2 |
0.0000 |
| 278 |
BACK PAIN |
7 |
0.0000 |
| 279 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 280 |
VIRAL INFECTION |
1 |
0.0000 |
| 281 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 282 |
GAIT INABILITY |
1 |
0.0000 |
| 283 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 284 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 285 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
6 |
0.0000 |
| 286 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 287 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 288 |
HAEMATURIA |
1 |
0.0000 |
| 289 |
INJURY |
2 |
0.0000 |
| 290 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 291 |
DYSARTHRIA |
1 |
0.0000 |
| 292 |
HOSPITALISATION |
4 |
0.0000 |
| 293 |
PALPITATIONS |
3 |
0.0000 |
| 294 |
BLINDNESS |
1 |
0.0000 |
| 295 |
CARDIAC ARREST |
2 |
0.0000 |
| 296 |
HYPERHIDROSIS |
3 |
0.0000 |
| 297 |
DEHYDRATION |
3 |
0.0000 |
| 298 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 299 |
INCORRECT DOSE ADMINISTERED |
5 |
0.0000 |
| 300 |
NASOPHARYNGITIS |
4 |
0.0000 |
| 301 |
CHEST PAIN |
4 |
0.0000 |
| 302 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 303 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 304 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 305 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 306 |
LUNG DISORDER |
1 |
0.0000 |
| 307 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
0.0000 |
| 308 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 309 |
SINUSITIS |
2 |
0.0000 |
| 310 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 311 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 312 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 313 |
PNEUMONIA |
6 |
0.0000 |
| 314 |
RASH PRURITIC |
1 |
0.0000 |
| 315 |
OFF LABEL USE |
16 |
0.0000 |
| 316 |
MEDICATION ERROR |
1 |
0.0000 |
| 317 |
SEPSIS |
2 |
0.0000 |
| 318 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 319 |
SURGERY |
1 |
0.0000 |
| 320 |
WHEEZING |
1 |
0.0000 |
| 321 |
ARTHRALGIA |
7 |
0.0000 |
| 322 |
CATARACT |
1 |
0.0000 |
| 323 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 324 |
DIZZINESS |
8 |
0.0000 |
| 325 |
SOMNOLENCE |
3 |
0.0000 |
| 326 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 327 |
VISION BLURRED |
2 |
0.0000 |
| 328 |
DRUG INEFFECTIVE |
19 |
0.0000 |
| 329 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 330 |
HOT FLUSH |
1 |
0.0000 |
| 331 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 332 |
DIABETES MELLITUS |
1 |
0.0000 |
| 333 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 334 |
PARAESTHESIA |
2 |
0.0000 |
| 335 |
FEELING ABNORMAL |
3 |
0.0000 |
| 336 |
PROSTATE CANCER |
1 |
0.0000 |
| 337 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 338 |
TREATMENT FAILURE |
1 |
0.0000 |
| 339 |
MYALGIA |
2 |
0.0000 |
| 340 |
RASH |
5 |
0.0000 |
| 341 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 342 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 343 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 344 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 345 |
SWELLING |
1 |
0.0000 |
| 346 |
DYSPNOEA |
6 |
0.0000 |
| 347 |
ANAEMIA |
2 |
0.0000 |
| 348 |
MIGRAINE |
1 |
0.0000 |
| 349 |
HEART RATE INCREASED |
1 |
0.0000 |
| 350 |
SYNCOPE |
1 |
0.0000 |
| 351 |
FLUSHING |
1 |
0.0000 |
| 352 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 353 |
HEADACHE |
6 |
0.0000 |
| 354 |
FATIGUE |
7 |
0.0000 |
| 355 |
INFLUENZA |
1 |
0.0000 |
| 356 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 357 |
ASTHMA |
1 |
0.0000 |
| 358 |
NAUSEA |
7 |
0.0000 |
| 359 |
PYREXIA |
3 |
0.0000 |
| 360 |
CHILLS |
1 |
0.0000 |
| 361 |
VOMITING |
4 |
0.0000 |
| 362 |
PAIN |
5 |
0.0000 |
| 363 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 364 |
WEIGHT DECREASED |
2 |
0.0000 |
| 365 |
MALAISE |
3 |
0.0000 |
| 366 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 367 |
HYPOAESTHESIA |
1 |
0.0000 |
| 368 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 369 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 370 |
DIARRHOEA |
4 |
0.0000 |
| 371 |
TREMOR |
1 |
0.0000 |
| 372 |
URTICARIA |
1 |
0.0000 |
| 373 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 374 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 375 |
ASTHENIA |
2 |
0.0000 |
| 376 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 377 |
ALOPECIA |
1 |
0.0000 |
| 378 |
ERYTHEMA |
1 |
0.0000 |
| 379 |
CONSTIPATION |
1 |
0.0000 |
| 380 |
WEIGHT INCREASED |
1 |
0.0000 |
| 381 |
DEPRESSION |
1 |
0.0000 |
| 382 |
DECREASED APPETITE |
1 |
0.0000 |
| 383 |
COUGH |
1 |
0.0000 |
| 384 |
DEATH |
3 |
0.0000 |
| 385 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 386 |
PRURITUS |
1 |
0.0000 |